Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for more information

CiteULike is a free service for managing and discovering scholarly references - click here to get started.

Sign In to gain access to subscriptions and/or personal tools.
Journal of Child Neurology
This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (8)
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Sumner, C. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sumner, C. J.
Right arrowPubmed/NCBI databases
*Genetics Home Reference
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Molecular Mechanisms of Spinal Muscular Atrophy

Charlotte J. Sumner, MD

Department of Neurology, Johns Hopkins University, Baltimore, Maryland, csumner1{at}jhmi.edu

Significant strides have been made during the past decade in the understanding of the molecular mechanisms that lead to the autosomal recessive motor neuron disease spinal muscular atrophy. Genetic studies revealed that spinal muscular atrophy is caused by mutation of the telomeric copy of the survival motor neuron gene ( SMN1), with all patients retaining at least one copy of the centromeric form of the gene, SMN2. SMN2 produces reduced amounts of full-length SMN messenger ribonucleic acid because of alterative splicing of SMN2 -derived transcripts, a process that is governed by specific cisand trans-acting factors. The resulting insufficient expression level of full-length SMN protein likely causes the disease manifestations of spinal muscular atrophy; however, the mechanism for the selective vulnerability of the motor unit to deficiency of this ubiquitously expressed protein remains unknown. It also remains unclear specifically when and where in the motor unit SMN is required. Despite the remaining questions, progress has been made in developing therapeutic strategies targeted to specific points along the pathogenetic pathway of spinal muscular atrophy. Histone deacetylase inhibitors will be discussed as an example.

Key Words: spinal muscular atrophy • motor neuron • survival motor neuron

References

  • Brzustowicz LM, Lehner T., Castilla LH, et al. Genetic mapping of chronic childhood-onset spinal muscular atrophy to chromosome 5q11.2-13.3. Nature. 1990;344:540-541.[CrossRef][Medline] [Order article via Infotrieve]
  • Melki J., Sheth P., Abdelhak S., et al. Mapping of acute (type I) spinal muscular atrophy to chromosome 5q12-q14. The French Spinal Muscular Atrophy Investigators. Lancet. 1990;336:271-273.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Lefebvre S., Burglen L., Reboullet S., et al. Identification and characterization of a spinal muscular atrophy-determining gene. Cell. 1995;80:155-165.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Lorson CL, Hahnen E., Androphy EJ, Wirth B. A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy. Proc Natl Acad Sci U S A. 1999;96:6307-6311.[Abstract/Free Full Text]
  • Monani UR, Lorson CL, Parsons DW, et al. A single nucleotide difference that alters splicing patterns distinguishes the spinal muscular atrophy gene SMN1 from the copy gene SMN2. Hum Mol Genet. 1999;8:1177-1183.[Abstract/Free Full Text]
  • Lefebvre S., Burlet P., Liu Q., et al. Correlation between severity and SMN protein level in spinal muscular atrophy. Nat Genet. 1997;16:265-269.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Coovert DD, Le TT, McAndrew PE, et al. The survival motor neuron protein in spinal muscular atrophy. Hum Mol Genet. 1997;6:1205-1214.[Abstract/Free Full Text]
  • Gavrilov DK, Shi X., Das K., et al. Differential SMN2 expression associated with spinal muscular atrophy severity. Nat Genet. 1998;20:230-231.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Soler-Botija C., Cusco I., Caselles L., et al. Implication of fetal SMN2 expression in type I spinal muscular atrophy pathogenesis: protection or pathological gain of function? J Neuropathol Exp Neurol. 2005;64:215-223.[Web of Science][Medline] [Order article via Infotrieve]
  • Parsons DW, McAndrew PE, Iannaccone ST, et al. Intragenic telSMN mutations: frequency, distribution, evidence of a founder effect, and modification of the spinal muscular atrophy phenotype by cenSMN copy number. Am J Hum Genet. 1998;63:1712-1723.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Feldkotter M., Schwarzer V., Wirth R., et al. Quantitative analyses of SMN1 and SMN2 based on real-time lightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy. Am J Hum Genet. 2002;70:358-368.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Prior TW, Swoboda KJ, Scott HD, Hejmanowski AQ Homozygous SMN1 deletions in unaffected family members and modification of the phenotype by SMN2. Am J Med Genet A. 2004;130:307-310.[Medline] [Order article via Infotrieve]
  • Wirth B., Brichta L., Schrank B., et al. Mildly affected patients with spinal muscular atrophy are partially protected by an increased SMN2 copy number. Hum Genet. 2006;119:422-428.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Monani UR, Sendtner M., Coovert DD, et al. The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn(-/-) mice and results in a mouse with spinal muscular atrophy. Hum Mol Genet. 2000;9:333-339.[Abstract/Free Full Text]
  • Sumner C., Kolb SJ, Harmison GG, et al. SMN mRNA and protein levels in peripheral blood: biomarkers for spinal muscular atrophy clinical trials. Neurology. 2006;66:1067-1073. Epub 2006 Feb 15.[Abstract/Free Full Text]
  • Simard LR, Belanger MC, Morissette S., et al. Preclinical validation of a multiplex real-time assay to quantify SMN mRNA in patients with spinal muscular atrophy. Neurology. 2007;68:451-456.[Abstract/Free Full Text]
  • Parano E., Pavone L., Falsaperla R., et al. Molecular basis of phenotypic heterogeneity in siblings with spinal muscular atrophy. Ann Neurol. 1996;40:247-251.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Lorson CL, Androphy EJ An exonic enhancer is required for inclusion of an essential exon in the spinal muscular atrophy-determining gene SMN. Hum Mol Genet. 2000;9:259-265.[Abstract/Free Full Text]
  • Cartegni L., Krainer AR Disruption of an SF2/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1. Nat Genet. 2002;30:377-384.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Kashima T., Manley JL A negative element in SMN2 exon 7 inhibits splicing in spinal muscular atrophy. Nat Genet. 2003;34: 460-463.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Cartegni L., Krainer AR Correction of disease-associated exon skipping by synthetic exon- specific activators. Nat Struct Biol. 2003;10:120-125.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Cartegni L., Hastings ML, Calarco JA, et al. Determinants of exon 7 splicing in the spinal muscular atrophy genes, SMN1 and SMN2. Am J Hum Genet. 2006;78:63-77.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Hofmann Y., Lorson CL, Stamm S., et al. Htra2-beta 1 stimulates an exonic splicing enhancer and can restore full-length SMN expression to survival motor neuron 2 (SMN2). Proc Natl Acad Sci U S A. 2000;97:9618-9623.[Abstract/Free Full Text]
  • Hofmann Y., Wirth B. hnRNP-G promotes exon 7 inclusion of survival motor neuron (SMN) via direct interaction with Htra2-beta1. Hum Mol Genet. 2002;11:2037-2049.[Abstract/Free Full Text]
  • Young PJ, DiDonato CJ, Hu D., et al. SRp30c-dependent stimulation of survival motor neuron (SMN) exon 7 inclusion is facilitated by a direct interaction with hTra2 beta 1. Hum Mol Genet. 2002;11:577-587.[Abstract/Free Full Text]
  • Miyajima H., Miyaso H., Okumura M., et al. Identification of a cisacting element for the regulation of SMN exon 7 splicing. J Biol Chem. 2002;277:23271-23277.[Abstract/Free Full Text]
  • Miyaso H., Okumura M., Kondo S., et al. An intronic splicing enhancer element in survival motor neuron (SMN) pre-mRNA. J Biol Chem. 2003;278:15825-15831.[Abstract/Free Full Text]
  • Singh NN, Androphy EJ, Singh RN In vivo selection reveals combinatorial controls that define a critical exon in the spinal muscular atrophy genes. RNA. 2004;10:1291-1305.[Abstract/Free Full Text]
  • Singh NK, Singh NN, Androphy EJ, Singh RN Splicing of a critical exon of human Survival Motor Neuron is regulated by a unique silencer element located in the last intron. Mol Cell Biol. 2006;26:1333-1346.[Abstract/Free Full Text]
  • Liu Q., Fischer U., Wang F., Dreyfuss G. The spinal muscular atrophy disease gene product, SMN, and its associated protein SIP1 are in a complex with spliceosomal snRNP proteins. Cell. 1997;90:1013-1021.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Patrizi AL, Tiziano F., Zappata S., et al. SMN protein analysis in fibroblast, amniocyte and CVS cultures from spinal muscular atrophy patients and its relevance for diagnosis. Eur J Hum Genet. 1999;7:301-309.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Zhang HL, Pan F., Hong D., et al. Active transport of the survival motor neuron protein and the role of exon-7 in cytoplasmic localization. J Neurosci. 2003;23:6627-6637.[Abstract/Free Full Text]
  • Zhang H., Xing L., Rossoll W., et al. Multiprotein complexes of the survival of motor neuron protein SMN with Gemins traffic to neuronal processes and growth cones of motor neurons. J Neurosci. 2006;26:8622-8632.[Abstract/Free Full Text]
  • Rossoll W., Jablonka S., Andreassi C., et al. Smn, the spinal muscular atrophy-determining gene product, modulates axon growth and localization of beta-actin mRNA in growth cones of motoneurons. J Cell Biol. 2003;163:801-812.[Abstract/Free Full Text]
  • Broccolini A., Engel WK, Askanas V. Localization of survival motor neuron protein in human apoptotic-like and regenerating muscle fibers, and neuromuscular junctions. Neuroreport. 1999;10: 1637-1641.
  • La Bella V., Cisterni C., Salaun D., Pettmann B. Survival motor neuron (SMN) protein in rat is expressed as different molecular forms and is developmentally regulated. Eur J Neurosci. 1998;10:2913-2923.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Jablonka S., Bandilla M., Wiese S., et al. Co-regulation of survival of motor neuron (SMN) protein and its interactor SIP1 during development and in spinal muscular atrophy. Hum Mol Genet. 2001;10:497-505.[Abstract/Free Full Text]
  • Kernochan LE, Russo ML, Woodling NS, et al. The role of histone acetylation in SMN gene expression. Hum Mol Genet. 2005;14:1171-1182.[Abstract/Free Full Text]
  • Paushkin S., Gubitz AK, Massenet S., Dreyfuss G. The SMN complex, an assemblyosome of ribonucleoproteins. Curr Opin Cell Biol. 2002;14:305-312.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Otter S., Grimmler M., Neuenkirchen N., Chari A., et al. A comprehensive interaction map of the human SMN-complex. J Biol Chem. 2007;282;5825-5833. Epub Dec 18, 2006.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Lorson CL, Strasswimmer J., Yao JM, et al. SMN oligomerization defect correlates with spinal muscular atrophy severity. Nat Genet. 1998;19:63-66.[Web of Science][Medline] [Order article via Infotrieve]
  • Cifuentes-Diaz C., Frugier T., Tiziano FD, et al. Deletion of murine SMN exon 7 directed to skeletal muscle leads to severe muscular dystrophy. J Cell Biol. 2001;152:1107-1114.[Abstract/Free Full Text]
  • Le TT, Pham LT, Butchbach ME, et al. SMNDelta7, the major product of the centromeric survival motor neuron (SMN2) gene, extends survival in mice with spinal muscular atrophy and associates with full-length SMN. Hum Mol Genet. 2005;14: 845-857.[Abstract/Free Full Text]
  • Yong J., Wan L., Dreyfuss G. Why do cells need an assembly machine for RNA-protein complexes? Trends Cell Biol. 2004; 14:226-232.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Will CL, Luhrmann R. Spliceosomal UsnRNP biogenesis, structure and function. Curr Opin Cell Biol. 2001;13:290-301.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • McWhorter ML, Monani UR, Burghes AH, Beattie CE Knockdown of the survival motor neuron (Smn) protein in zebrafish causes defects in motor axon outgrowth and pathfinding. J Cell Biol. 2003;162:919-931.[Abstract/Free Full Text]
  • Miguel-Aliaga I., Culetto E., Walker DS, et al. The Caenorhabditis elegans orthologue of the human gene responsible for spinal muscular atrophy is a maternal product critical for germline maturation and embryonic viability. Hum Mol Genet. 1999;8: 2133-2143.[Abstract/Free Full Text]
  • Miguel-Aliaga I., Chan YB, Davies KE, van den Heuvel M. Disruption of SMN function by ectopic expression of the human SMN gene in Drosophila. FEBS Lett. 2000;486:99-102.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Schrank B., Gotz R., Gunnersen JM, et al. Inactivation of the survival motor neuron gene, a candidate gene for human spinal muscular atrophy, leads to massive cell death in early mouse embryos. Proc Natl Acad Sci U S A. 1997;94:9920-9925.[Abstract/Free Full Text]
  • Hsieh-Li HM, Chang JG, Jong YJ, et al. A mouse model for spinal muscular atrophy. Nat Genet. 2000;24:66-70.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Monani UR, Pastore MT, Gavrilina TO, et al. A transgene carrying an A2G missense mutation in the SMN gene modulates phenotypic severity in mice with severe (type I) spinal muscular atrophy. J Cell Biol. 2003;160:41-52.[Abstract/Free Full Text]
  • Wan L., Battle DJ, Yong J., et al. The survival of motor neurons protein determines the capacity for snRNP assembly: biochemical deficiency in spinal muscular atrophy. Mol Cell Biol. 2005; 25:5543-5551.[Abstract/Free Full Text]
  • Winkler C., Eggert C., Gradl D., et al. Reduced U snRNP assembly causes motor axon degeneration in an animal model for spinal muscular atrophy. Genes Dev. 2005;19:2320-2330.[Abstract/Free Full Text]
  • Carrel TL, McWhorter ML, Workman E., et al. Survival motor neuron function in motor axons is independent of functions required for small nuclear ribonucleoprotein biogenesis. J Neurosci. 2006;26:11014-11022.[Abstract/Free Full Text]
  • Wharton, S., Ince PG Pathology of motor neuron disorders. In: Shaw PJ, Strong MJ, eds. Motor Neuron Disorders. Philadelphia, PA: Butterworth Heinemann; 2003:17-49.
  • Fidzianska A., Goebel HH, Warlo I. Acute infantile spinal muscular atrophy. Muscle apoptosis as a proposed pathogenetic mechanism. Brain. 1990;113( Pt 2):433-445.[Abstract/Free Full Text]
  • Soubrouillard C., Pellissier JF, Lepidi H., et al. Expression of developmentally regulated cytoskeleton and cell surface proteins in childhood spinal muscular atrophies. J Neurol Sci. 1995;133: 155-163.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Arnold AS, Gueye M., Guettier-Sigrist S., et al. Reduced expression of nicotinic AChRs in myotubes from spinal muscular atrophy I patients. Lab Invest. 2004;84:1271-1278.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Shafey D., Cote PD, Kothary R. Hypomorphic Smn knockdown C2C12 myoblasts reveal intrinsic defects in myoblast fusion and myotube morphology. Exp Cell Res. 2005;311:49-61.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Braun S., Croizat B., Lagrange MC, et al. Constitutive muscular abnormalities in culture in spinal muscular atrophy. Lancet. 1995;345:694-695.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Nicole S., Desforges B., Millet G., et al. Intact satellite cells lead to remarkable protection against Smn gene defect in differentiated skeletal muscle. J Cell Biol. 2003;161:571-582.[Abstract/Free Full Text]
  • Chan YB, Miguel-Aliaga I., Franks C., et al. Neuromuscular defects in a Drosophila survival motor neuron gene mutant. Hum Mol Genet. 2003;12:1367-1376.[Abstract/Free Full Text]
  • Funakoshi H., Belluardo N., Arenas E., et al. Muscle-derived neurotrophin-4 as an activity-dependent trophic signal for adult motor neurons. Science. 1995;268:1495-1499.[Abstract/Free Full Text]
  • Sumner CJ Therapeutics development for spinal muscular atrophy. NeuroRx. 2006;3:235-245.[CrossRef][Medline] [Order article via Infotrieve]
  • Minucci S., Pelicci PG Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer. Nat Rev Cancer. 2006;6:38-51.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Chang JG, Hsieh-Li HM, Jong YJ, et al. Treatment of spinal muscular atrophy by sodium butyrate. Proc Natl Acad Sci U S A. 2001;98:9808-9813.[Abstract/Free Full Text]
  • Sumner CJ, Huynh TN, Markowitz JA, et al. Valproic acid increases SMN levels in spinal muscular atrophy patient cells. Ann Neurol. 2003;54:647-654.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Brichta L., Hofmann Y., Hahnen E., et al. Valproic acid increases the SMN2 protein level: a well-known drug as a potential therapy for spinal muscular atrophy. Hum Mol Genet. 2003;12: 2481-2489.[Abstract/Free Full Text]
  • Andreassi C., Angelozzi C., Tiziano FD, et al. Phenylbutyrate increases SMN expression in vitro: relevance for treatment of spinal muscular atrophy. Eur J Hum Genet. 2004;12:59-65.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Avila A., Burnett BG, Taye AA, et al. Trichostatin A increases SMN expression and survival in a mouse model of spinal muscular atrophy. J Clin Invest. 2007;117:659-671.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Hirtz D., Iannaccone S., Heemskerk J., et al. Challenges and opportunities in clinical trials for spinal muscular atrophy. Neurology. 2005;65:1352-1357.[Abstract/Free Full Text]
  • Weihl CC, Connolly AM, Pestronk A. Valproate may improve strength and function in patients with type III/IV spinal muscle atrophy. Neurology. 2006;67:500-501.[Abstract/Free Full Text]
  • Mercuri E., Bertini E., Messina S., et al. Randomized, double-blind, placebo-controlled trial of phenylbutyrate in spinal muscular atrophy. Neurology. 2007;68:51-55.[Abstract/Free Full Text]
  • Marks PA, Dokmanovic M. Histone deacetylase inhibitors: discovery and development as anticancer agents. Expert Opin Investig Drugs. 2005;14:1497-1511.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Journal of Child Neurology, Vol. 22, No. 8, 979-989 (2007)
DOI: 10.1177/0883073807305787
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 J Child NeurolHome page
R. A. Brumback
Child Neurologists Should Be Interested In Brain Tumors!
J Child Neurol, November 1, 2009; 24(11): 1338 - 1340.
[PDF]

Home page
 NeurologyHome page
N. Preisler, G. Andersen, F. Thogersen, C. Crone, T. D. Jeppesen, F. Wibrand, and J. Vissing
Effect of aerobic training in patients with spinal and bulbar muscular atrophy (Kennedy disease)
Neurology, January 27, 2009; 72(4): 317 - 323.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
C. G. Bonnemann and R. S. Finkel
Linking SMN to SMA: An assay for the rescuer
Neurology, November 25, 2008; 71(22): 1752 - 1753.
[Full Text] [PDF]

Home page
 Hum Mol GenetHome page
M. P. Walker, T.K. Rajendra, L. Saieva, J. L. Fuentes, L. Pellizzoni, and A. G. Matera
SMN complex localizes to the sarcomeric Z-disc and is a proteolytic target of calpain
Hum. Mol. Genet., November 1, 2008; 17(21): 3399 - 3410.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
S. B. Patel and M. Bellini
The assembly of a spliceosomal small nuclear ribonucleoprotein particle
Nucleic Acids Res., November 1, 2008; 36(20): 6482 - 6493.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (8)
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Sumner, C. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sumner, C. J.
Right arrowPubmed/NCBI databases
*Genetics Home Reference
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?